-
2
-
-
77953028103
-
Chagas disease: A Latin American health problem becoming a world health problem
-
Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 2010; 115:14-21.
-
(2010)
Acta Trop
, vol.115
, pp. 14-21
-
-
Schmunis, G.A.1
Yadon, Z.E.2
-
3
-
-
70149108335
-
An estimate of the burden of Chagas disease in the United States
-
Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009; 49:e52-4.
-
(2009)
Clin Infect Dis
, vol.49
, pp. e52-e54
-
-
Bern, C.1
Montgomery, S.P.2
-
4
-
-
84937002067
-
Access to care for Chagas disease in the United States: A health systems analysis
-
Manne-Goehler J, Reich MR, Wirtz VJ. Access to care for Chagas disease in the United States: a health systems analysis. Am J Trop Med Hyg 2015; 93:5.
-
(2015)
Am J Trop Med Hyg
, vol.93
, pp. 5
-
-
Manne-Goehler, J.1
Reich, M.R.2
Wirtz, V.J.3
-
5
-
-
84875614866
-
Global economic burden of Chagas disease: A computational simulation model
-
Lee BY, Bacon KM, Bottazzi ME, Hotez PJ. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis 2013; 13:342-8.
-
(2013)
Lancet Infect Dis
, vol.13
, pp. 342-348
-
-
Lee, B.Y.1
Bacon, K.M.2
Bottazzi, M.E.3
Hotez, P.J.4
-
8
-
-
79959793199
-
Antitrypanosomal therapy for Chagas' disease
-
Bern C. Antitrypanosomal therapy for Chagas' disease. N Engl J Med 2011; 364:7.
-
(2011)
N Engl J Med
, vol.364
, pp. 7
-
-
Bern, C.1
-
9
-
-
0036359943
-
A critical review on Chagas disease chemotherapy
-
Coura JR, de Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002; 97:21.
-
(2002)
Mem Inst Oswaldo Cruz
, vol.97
, pp. 21
-
-
Coura, J.R.1
De Castro, S.L.2
-
10
-
-
17544400692
-
Long-term evaluation of etiological treatment of Chagas disease with benznidazole
-
Cançado JR. Long-term evaluation of etiological treatment of Chagas disease with benznidazole. Rev Inst Med Trop Sao Paulo 2002; 44:8.
-
(2002)
Rev Inst Med Trop Sao Paulo
, vol.44
, pp. 8
-
-
Cançado, J.R.1
-
12
-
-
33646847271
-
Long-term outcomes of treating chronic Chagas disease with benznidazole versus no treatment
-
Viotti R, Vigliano C, Bertocchi G, et al. Long-term outcomes of treating chronic Chagas disease with benznidazole versus no treatment. Ann Intern Med 2006; 144:10.
-
(2006)
Ann Intern Med
, vol.144
, pp. 10
-
-
Viotti, R.1
Vigliano, C.2
Bertocchi, G.3
-
13
-
-
34248531970
-
Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe City (Argentina), over a mean follow-up of 21 years: Parasitological, serological, and clinical evolution
-
Fabbro DL, Streiger Ml, Arias ED, Bizai ML, del Barco M, Amicone NA. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe City (Argentina), over a mean follow-up of 21 years: parasitological, serological, and clinical evolution. Revista de Sociedade Brasileira de Medicina Tropical 2007; 40:10.
-
(2007)
Revista de Sociedade Brasileira de Medicina Tropical
, vol.40
, pp. 10
-
-
Fabbro, D.L.1
Streiger, M.L.2
Arias, E.D.3
Bizai, M.L.4
Del Barco, M.5
Amicone, N.A.6
-
14
-
-
84942265029
-
Randomized trial of benznidazole for chronic Chagas' cardiomyopathy
-
Morillo CA, Marin-Neto JA, Avezum A, et al. Randomized trial of benznidazole for chronic Chagas' cardiomyopathy. N Engl J Med 2015; 373:1295-306.
-
(2015)
N Engl J Med
, vol.373
, pp. 1295-1306
-
-
Morillo, C.A.1
Marin-Neto, J.A.2
Avezum, A.3
-
15
-
-
78349302742
-
Tolerance and safety of nifurtimox in patients with chronic Chagas disease
-
Jackson Y, Alirol E, Getaz L, Wolff H, Combescure C, Chappuis F. Tolerance and safety of nifurtimox in patients with chronic Chagas disease. Clin Infect Dis 2010; 51:e69-75.
-
(2010)
Clin Infect Dis
, vol.51
, pp. e69-e75
-
-
Jackson, Y.1
Alirol, E.2
Getaz, L.3
Wolff, H.4
Combescure, C.5
Chappuis, F.6
-
16
-
-
36148997207
-
Evaluation and treatment of Chagas disease in the United States: A systematic review
-
Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007; 298:10.
-
(2007)
JAMA
, vol.298
, pp. 10
-
-
Bern, C.1
Montgomery, S.P.2
Herwaldt, B.L.3
-
17
-
-
64049108552
-
Side effects of benznidazole as treatment in chronic Chagas disease: Fears and realities
-
Viotti R, Vigliano C, Lococo B, Alvarez MG, Bertocchi G, Armenti A. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Rev Anti Infect Ther 2009; 7:7.
-
(2009)
Expert Rev Anti Infect Ther
, vol.7
, pp. 7
-
-
Viotti, R.1
Vigliano, C.2
Lococo, B.3
Alvarez, M.G.4
Bertocchi, G.5
Armenti, A.6
-
18
-
-
84926664889
-
Tolerance of benznidazole in a United States Chagas disease clinic
-
Miller DA, Hernandez S, Rodriguez De Armas L, et al. Tolerance of benznidazole in a United States Chagas disease clinic. Clin Infect Dis 2015; 60:1237-40.
-
(2015)
Clin Infect Dis
, vol.60
, pp. 1237-1240
-
-
Miller, D.A.1
Hernandez, S.2
Rodriguez De Armas, L.3
-
19
-
-
84991011812
-
-
Centers for Disease Control and Prevention. NewsBites: Spotlight on CDC's Parasitic Disease Work. Atlanta, GA: CDC
-
Centers for Disease Control and Prevention. Coming together on Chagas disease. NewsBites: Spotlight on CDC's Parasitic Disease Work. Atlanta, GA: CDC, 2015.
-
(2015)
Coming Together on Chagas Disease
-
-
-
20
-
-
84990884650
-
Tratamiento de la enfermedad de Chagas crónica en Chile Efectos adversos de nifurtimox [in Spanish]
-
Valencia CN, Mancilla M, Ramos D, et al. Tratamiento de la enfermedad de Chagas crónica en Chile. Efectos adversos de nifurtimox [in Spanish]. Rev Ibero-Laintoam Parasitol 2012; 71:11.
-
(2012)
Rev Ibero-Laintoam Parasitol
, vol.71
, pp. 11
-
-
Valencia, C.N.1
Mancilla, M.2
Ramos, D.3
-
21
-
-
84949673066
-
Safety profile of nifurtimox and treatment interruption for chronic Chagas disease in Colombian adults
-
Olivera MJ, Cucunuba ZM, Alvarez CA, Nicholls RS. Safety profile of nifurtimox and treatment interruption for chronic Chagas disease in Colombian adults. Am J Trop Med Hyg 2015; 93:1224-30.
-
(2015)
Am J Trop Med Hyg
, vol.93
, pp. 1224-1230
-
-
Olivera, M.J.1
Cucunuba, Z.M.2
Alvarez, C.A.3
Nicholls, R.S.4
-
22
-
-
84877661272
-
Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment
-
Perez-Molina JA, Sojo-Dorado J, Norman F, et al. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment. Acta Trop 2013; 127:101-4.
-
(2013)
Acta Trop
, vol.127
, pp. 101-104
-
-
Perez-Molina, J.A.1
Sojo-Dorado, J.2
Norman, F.3
-
26
-
-
84992144353
-
-
National Cancer Institute. Bethesda, MD: U.S. Department of Health and Human Services
-
National Cancer Institute. Common Terminology Criteria for Adverse Events, version 4.03. Bethesda, MD: U.S. Department of Health and Human Services, 2010.
-
(2010)
Common Terminology Criteria for Adverse Events, Version 4.03
-
-
-
27
-
-
33748669644
-
Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)
-
Castro JA, Montalto de Mecca M, Bartel LC. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Hum Exp Toxicol 2006; 25:8.
-
(2006)
Hum Exp Toxicol
, vol.25
, pp. 8
-
-
Castro, J.A.1
Montalto De Mecca, M.2
Bartel, L.C.3
-
28
-
-
0025126590
-
Malignant, non-Hodgkin's lymphomas in Trypanosoma cruzi-infected rabbits treated with nitroarenes
-
Teixeira AR, Silva R, Cunha Neto E, Santana JM, Rizzo LV. Malignant, non-Hodgkin's lymphomas in Trypanosoma cruzi-infected rabbits treated with nitroarenes. J Comp Pathol 1990; 103:11.
-
(1990)
J Comp Pathol
, vol.103
, pp. 11
-
-
Teixeira, A.R.1
Silva, R.2
Cunha Neto, E.3
Santana, J.M.4
Rizzo, L.V.5
-
29
-
-
84924031840
-
Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia
-
Bianchi F, Cucunubia Z, Guhl F, et al. Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia. PLoS Negl Trop Dis 2015; 9.
-
(2015)
PLoS Negl Trop Dis
, pp. 9
-
-
Bianchi, F.1
Cucunubia, Z.2
Guhl, F.3
-
30
-
-
84953853524
-
Current drug therapy and pharmaceutical challenges for Chagas disease
-
Bermudez J, Davies C, Simonazzi A, Pablo Real J, Palma S. Current drug therapy and pharmaceutical challenges for Chagas disease. Acta Trop 2016; 156:1-16.
-
(2016)
Acta Trop
, vol.156
, pp. 1-16
-
-
Bermudez, J.1
Davies, C.2
Simonazzi, A.3
Pablo Real, J.4
Palma, S.5
-
31
-
-
84942914027
-
Toxic profile of benznidazole in patients with chronic Chagas disease: Risk factors and comparison of the product from two different manufacturers
-
Molina I, Salvador F, Sanchez-Montalva A, et al. Toxic profile of benznidazole in patients with chronic Chagas disease: risk factors and comparison of the product from two different manufacturers. Antimicrob Agents Chemother 2015; 59:6125-31.
-
(2015)
Antimicrob Agents Chemother
, vol.59
, pp. 6125-6131
-
-
Molina, I.1
Salvador, F.2
Sanchez-Montalva, A.3
-
32
-
-
0346971251
-
-
Accessed 13 May
-
Bayer AG. Chagas disease. Available at: http://pharma.bayer.com/en/commitmentresponsibility/ neglected-diseases/chagas-disease/. Accessed 13 May 2016.
-
(2016)
Chagas Disease
-
-
Bayer, A.G.1
|